Barriers Cancer patients Congruence Family caregivers Pain management Background: Both cancer patients and their family caregivers (FCs) report concerns about pain and pain management. When dyads share appraisal of the illness context, they may experience better dyadic adjustment. Objective: The aim of this study was to compare oncology outpatients' and their FCs' attitudes and concerns toward pain and pain management. Methods: In a cross-sectional study, outpatients with pain (n = 71) and their FCs completed the Barriers Questionnaire II, the Brief Pain Inventory, and information about demographic characteristics. Correlations and paired-samples t tests were calculated to evaluate agreement and differences in barrier scores between the patients and their FCs. Results: Congruence was found in patients' and FCs' beliefs about pain and the use of analgesics on 4 of 7 subscales (ie, tolerance, immune system, side effects, distract the medical doctor) and on the Barriers Questionnaire II total score. Both patients and their FCs were most concerned about addiction. Conclusions: The concerns that both patients and their FCs have about pain and the use of analgesics may act as barriers to effective pain management. Fear of addiction may be an important barrier to cancer pain management. Only small differences were found in concerns between the patients and their FCs. Implications for Practice: Patients and FCs need education about perceived barriers to effective pain management. They should be coached together to maintain or increase the congruence between them.
T he role of family caregivers (FCs) is changing as most cancer patients get treatment in outpatient clinics. Unrelieved pain in cancer patients remains a significant clinical problem. 1, 2 Compared with hospitalized patients, oncology outpatients and their FCs face greater challenges when making daily decisions about pain management. Most FCs are actively engaged in assisting with pain management and experience significant needs and concerns related to this role. 3, 4 Prior research indicates that decreases in FCs' quality of life parallel decrements in patients' physical and psychological well-being. 5, 6 Both patients and their FCs may be reluctant to report pain and to use adequate amounts of analgesics. This reluctance may be based on erroneous beliefs or misconceptions about pain and its management, which act as barriers to effective pain management. 7Y11 A systematic review of barriers to effective cancer pain mangement found that patients were most concerned about addiction and side effects of analgesics and interpreted increased pain to be progression of their disease. 12 While concern about addiction was the most common barrier in subsequent studies, 8, 13 the specific reported barriers varied across studies. For example, in 1 study, 13 patients had the fewest misconceptions about the side effects of analgesics. Other patients had concerns about the development of tolerance to analgesics. 8 These differences may be related to the evaluation of patients at different stages of their disease trajectory as well as cultural differences. 14 Family caregivers of oncology patients also report barriers to pain management. In 1 study, 9 between 46% and 94% of FCs reported at least some agreement with a number of barriers listed on the Barriers Questionnaire (BQ), and up to 15% reported strong agreement. In another study, 10 87% of the FCs of patients receiving home hospice care had concerns about the pharmacologic management of pain. Similar to patients, fear of addiction was the most common barrier reported by FCs. 4 The developmental-contextual model of dyads coping with illness proposes that dyads should work together as a unit to appraise, cope, and adjust to the illness experience. The dyadic reaction to an illness, like cancer, has an impact on the adjustments of both patients and their FCs. Spouses may react to the patients' illness in similar or different ways than the patients that can affect the ways that dyads cope. 15 Therefore, congruence between patients' and FCs' beliefs and attitudes toward pain management may influence their communications about coping with and management of the patients' pain.
Only 2 studies evaluated the congruence between patient and FC dyads' concerns and attitudes toward pain and pain management. 16, 17 In 1 study, 17 barriers to pain management were evaluated in a sample of 35 palliative cancer patients and their FCs before admission to hospice. Only a weak correlation was found between patients' and their FCs' ratings regarding fatalistic notions about treatment of cancer pain. In addition, no differences were found between patients' and FCs' scores on the BQ, except that patients reported higher scores on the subscale concerning the desire ''to be a good patient.'' This finding suggests that either the patients or their FCs had a higher level of concern about reporting pain or the use of analgesics. The sample size for this study was very small, and it is not clear whether findings from palliative patients and their FCs can be generalized to oncology outpatients and their FCs.
In contrast to the study by Ward et al, 17 in a study of 159 oncology outpatients and their FCs, 16 statistically significant correlations were found between dyads on all of the subscales and the total BQ score. The highest correlations were found for the ''addiction'' (r = 0.48) and ''side effects'' (r = 0.48) subscale scores. In addition, patients scored significantly higher on the subscales ''distracting the medical doctor,'' ''tolerance,'' ''religious beliefs,'' ''medication should be taken as needed (PRN),'' and total BQ scores.
Given the paucity of research on the congruence between patients' and FCs' perceptions of barriers to effective cancer pain management and the notion that a lack of congruence in dyadic concerns may result in poorer pain control, the purposes of this study, in a sample of oncology outpatients and their FCs, were to examine the strength of the associations between patients' and FCs' responses to the BQ-II questionnaire and to evaluate which member of the dyad had higher subscale and total BQ scores. We hypothesized that patients' and FCs' responses would be highly correlated and that no differences would be found in the subscale and total BQ scores between patients and FCs.
n Methods
Sample and Data Collection
This descriptive, cross-sectional study is part of a larger epiemiologic study of cancer pain management 18Y20 that evaluated the occurrence and characteristics of pain and analgesic use in a large oncology outpatient clinic in Norway. Patients (n = 217) were recruited from outpatient oncology clinics (ie, general, gynecology, lung, pain, chemotherapy, and radiotherapy) in a large, tertiary referral cancer hospital in Norway. Most of the patients at this facility had solid tumors and required radiotherapy and/or complex chemotherapy regimens for treatment of primary or metastatic disease. Some of the patients were seen for regular follow-up visits. Patients were included if they were older than 18 years, had a diagnosis of cancer, self-reported pain of any intensity and/or use of analgesics, and were able to read, write, and understand Norwegian.
Patients who consented to participate were asked if the researcher could contact their FC to obtain their consent to participate in the study. A total of 97 patients gave their permission to contact their FC. The FCs were given written information about the study and provided written informed consent. A total of 71 FCs consented and completed the study questionnaires, a response rate of 73%. Only patients with an FC who consented to participate were included in the study. This study was approved by the Regional Ethics Committee, the Norwegian Radium Hospital's protocol review system, and the data inspectorate. status, and the relationship between the patient and the FC. To obtain data on cancer diagnosis and the presence of metastasis, a physician or a research assistant reviewed the patients' medical records. Patients' functional status was measured by self-report using the Karnofsky Performance Status (KPS) scale. 21Y23 The KPS score in this study ranged from 40 (disabled, need special help and care) to 100 (adequate health status with no complaints and no evidence of disease). The KPS is a valid and reliable self-report measure of the functional status of patients with cancer.
BARRIERS QUESTIONNAIRE
The 27-item BQ-II is the revised version of the BQ that measures beliefs about cancer pain and the use of analgesics that can act as barriers to pain management. 7 Participants rated the extent to which they agreed with each statement on a Likert scale that ranged from 0 (do not agree) to 5 (agree very much), with higher scores indicating stronger barriers. In order to compare the results to prior studies, 4,15 the subscales ''addiction,'' ''tolerance,'' ''fatalism,'' ''side effects,'' ''desire to be good'' (eg, good patients do not complain about pain), and ''distracting the medical doctor'' are the same as the original BQ. The more recent subscales of the BQ-II are ''monitoring'' (eg, analgesics may block or mask one's ability to monitor symptoms) and ''immune function.'' 7 The subscale and total scores can range from 0 to 5. In this study, the total score for the Norwegian version of the BQ-II had a Cronbach's ! of .89. 8 
PAIN CHARACTERISTICS
The Brief Pain Inventory 24 was used to evaluate pain intensity, pain interference, and pain relief in the last 24 hours. Pain intensity scores were rated using a 0 (no pain) to 10-point (worst pain imaginable) numeric rating scale (NRS). Pain relief was rated on a 0% (no relief) to 100% (completely relief) NRS. Pain interference with 7 functions was measured using 0 (does not interfere) to 10 (completely interference) NRSs. The Norwegian version of the Brief Pain Inventory has satisfactory psychometric properties. 25 Categories of pain severity were determined from the worst pain intensity scores (ie, 1Y4 = mild pain, 5Y6 = moderate pain, and 7Y10 = severe pain). 26 
Statistical Analyses
All analyses were done using the Statistical Package for the Social Sciences (SPSS Inc, Chicago, Illinois) version 20. Descriptive statistics were used to present demographic and clinical characteristics of the patients and demographic characteristics of the FCs, as well as the scores from the individual BQ-II items. To identify differences between patients' and FCs' ratings, paired t tests were done on the subscales and the total BQ-II scores, and matched paired Wilcoxin tests were done on the individual ordinal BQ-II items. In addition, correlations were done to explore the strength of the associations between patients' and the FCs' ratings for the subscale and total BQ-II scores. P < .05 was considered statistically significant.
n Results
Characteristics of the Sample
Patients' demographics and clinical characteristics are shown in Table 1 . The majority of the patients were female and married with a mean age of 56.0 (SD, 12.0) years and a range from 24 to 86 years. The majority were not employed and had a secondary school or university education. The majority had breast cancer, and half of the sample had metastatic disease. The mean KPS score was 74.7 (SD, 11.5), with a range from 40 to 90.
The majority of the FCs were male and worked either full or part time, and their mean age was 55.1 (SD, 11.0) years, with a range from 23 to 78 years. Ninety percent were married to the patient (Table 1 ). The patients' pain characteristics are summarized in Table 2 . Fifty-seven percent of the patients were characterized as having moderate or severe pain. Total pain interference with function was 4.2 (SD, 2.3), with a range from 0 to 9. The patients had a mean pain relief score of 59.7% (SD, 29.9%).
Differences in Patients' and FCs' Ratings of the BQ-II Items, Subscales, and Total Scores
As shown in Table 3 , except for the ''fatalism'' subscale of the BQ-II, no differences in mean scores were found between patients and FCs on any of the subscales or total scores. However, although not large in magnitude, the correlation between patients' and their FCs' scores was statistically significant for the ''tolerance,'' ''immune system,'' ''side effects,'' ''distract the MD'' subscales, and the total BQ-II scores ( Table 3 ). In addition, compared with FCs, patients reported higher scores on 1 ''addition'' item, 2 ''monitoring'' items, and 2 ''desire to be good'' items. Family caregivers reported higher scores than did the patients on 1 ''fatalism'' item and 1 ''side effect'' item ( Table 4 ).
n Discussion
This study is one of the first to evaluate congruence between cancer patients' and their FCs' ratings of barriers to pain management. Except for fatalism, patients and FCs did not differ in average magnitude. Although none of the correlations are very strong, the dyads were significantly correlated in their ratings for 4 of 7 subscales (ie, ''tolerance,'' ''immune system,'' ''distract the MD,'' ''side effects''), as well as the total BQ-II scores. These findings are in sharp contrast to a previous study that found that dyads were only congruent on the fatalism subscale of the BQ. 17 However, they are consistent with a more recent study that found congruence in 5 of 9 subscales (ie, ''fatalism,'' ''addiction,'' ''desire to be good,'' ''side effects,'' and ''disease progression''). 16 These inconsistent findings may be partially explained by the fact that the study by Ward et al 17 was published over 18 years ago. In the past 2 decades, oncology clinicians have focused on improving pain management 27 and involving FCs in pain management. 4, 28, 29 Another reason for the inconsistent findings can be variations in gender distribution among the studies. In our study, 80% of the patients were female, whereas the 2 previous studies both had a distribution of 50% female patients. 16, 17 However, because the results from these 2 previous studies differ, further research is needed in this area. Education of both patients' and FCs' concerns and negative attitudes toward pain management in both members of the dyads 30,31 may lead to more congruence between patients' and their FCs' concerns and attitudes toward pain and pain management.
For 3 of the subscales (ie, ''desire to be good,'' ''monitor,'' ''addiction''), no differences in mean scores or significant correlations were found. This finding suggests that in a given dyad it is equally possible for the patient or the FC to have greater concerns. To explain this finding further, we evaluated for dyadic differences in scores for the single items on each of these subscales (Table 4) .
For the ''desire to be good'' subscale, patients had higher barrier scores for 2 of the items that concerned talking about pain. One explanation may be that patients do not want to distress their FCs further by talking about their pain. This hypothesis is supported by the fact that less than half of the patients gave consent to enroll their FC in the study. Many patients explained that they did not want to increase the strain their FCs were experiencing. In addition, a previous study found that because patients do not want to upset their loved ones, they avoid talking about their feelings and concerns. 32 For the ''monitor'' subscale, patients scored higher than did their FCs on 1 item that addressed pain medications' ability to block new pain and another that addressed the ability of pain medicines to mask changes in their health. One explanation could be that the patients wanted to be able to monitor changes in the status of their cancer. Previous research found that oncology patients often associate pain with cancer progression. 33, 34 Therefore, they may be unwilling to take a sufficient amount of pain medication to be able to identify changes in their medical condition. This hypothesis is supported by the fact that patients in this study reported only approximately 60% pain relief and that for 57% of the patients their pain was in the moderate-to-severe range. For the ''addiction'' subscale, patients scored higher than did their FCs on the item that stated that pain medicine is very addictive. However, prior studies found that both patients and their FCs are most concerned about addiction. 9, 12, 13, 35 Myths and fears about opioid use remain widespread across cultures and across care settings. 4 Antidrug campaigns that attempt to combat trafficking and demand for illicit drugs as well as abuse of prescription opioids may contribute to the perception that analgesics are dangerous even when they are used for the management of cancer pain.
Consistent with previous studies, 7,16,17,34,36Y41 both patients and FCs in Norway have barriers to pain management that may contribute to inadequate pain management. An examination of differences in patients' and FCs' BQ scores, between the Norwegian sample and other samples, found some differences. For example, medium to large differences in total BQ scores were found between the Norwegian FCs and FCs in 2 studies from Taiwan, in which Taiwanese cancer patients reported higher barriers scores (effect sizes, j0.42 16 and j0.57 11 ), and FCs from the United States reported lower barrier scores (effect size, 0.29 17 ). 42 In terms of patients' total 36 ), whereas another found a slightly higher BQ score in the United States (effect size, j0.25 34 ).
Meeker and colleagues 4 concluded in their review about the FCs' role in cancer pain management that FCs need education about pain management, training in problem-solving skills, and recognition from clinicians about their role in pain management. When clinicians better understand and respond to the needs of FCs, they can enhance the quality of life and care outcomes for both patients and their FCs. 4 Oncology nurses need to be aware that patients and FCs may benefit from being coached together about barriers as both patients and their FCs are involved in pain management. In a study by Rustøen et al, 29 they used a short knowledge and attitude survey (ie, the Pain Experience Scale [PES] 43 ), as part of a psychoeducational intervention. The PES provided an effective foundation for patients' and FCs' education about cancer pain management. Nurses can use this individualized approach to educate patients and FCs about pain management. The use of the PES to focus educational content may save staff time and improve patient outcomes. Because cancer patients' pain experience may disrupt family communication, 32, 44 it is important to talk to both patients and their FCs together.
Several study limitations need to be acknowledged. The study was cross-sectional and did not allow for an evaluation of changes over time in patients' and FCs' congruence in attitudes and concerns about pain management. In addition, because only a single site was used for recruitment, these findings may not generalize across other settings. Finally, because only onethird of the patients gave permission to ask their FC to participate in this study, the findings may not generalize to all FCs on oncology patients with pain. It may be that the FCs with the highest barriers were not included in the present study. A similar study with a larger sample may detect additional differences between patients and their FCs.
Additional research is needed to examine whether increased congruence in patients' and FCs' barriers to pain management can enhance the dyadic adjustment as proposed by the developmental-contextual model. 15 
